This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Strength Seen in Tetra (TTEK): Can Its 8.4% Jump Turn into More Strength?
by Zacks Equity Research
Tetra (TTEK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Sharps Compliance (SMED) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sharps Compliance (SMED) delivered earnings and revenue surprises of -125% and 5.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Casella (CWST) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Casella (CWST) delivered earnings and revenue surprises of 22.22% and 5.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Hubbell (HUBB) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Hubbell (HUBB) delivered earnings and revenue surprises of 13.98% and 6.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Plug Power (PLUG) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Plug Power's (PLUG) Q4 earnings are likely to have gained from the growing popularity of fuel-cell solutions. High costs and operating expenses, supply-chain issues and forex woes might have hurt.
Sharps Compliance (SMED) Misses Q2 Earnings Estimates
by Zacks Equity Research
Sharps Compliance (SMED) delivered earnings and revenue surprises of -12.50% and 2.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Sharps Compliance (SMED) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Sharps Compliance (SMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sharps Compliance (SMED) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sharps Compliance (SMED) delivered earnings and revenue surprises of -33.33% and 3.17%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Sharps Compliance (SMED) Q1 Earnings Expected to Decline
by Zacks Equity Research
Sharps Compliance (SMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 23rd
by Zacks Equity Research
TTCF, SMED, KRO, EAR, and CDK have been added to the Zacks Rank #5 (Strong Sell) List on August 23, 2021
Sharps Compliance (SMED) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Sharps Compliance (SMED) delivered earnings and revenue surprises of -19.05% and -22.13%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Sharps Compliance (SMED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Sharps Compliance (SMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zebra (ZBRA) to Buy Fetch Robotics, Enhance Product Offerings
by Zacks Equity Research
Zebra's (ZBRA) buyout of Fetch Robotics will enable it to offer a comprehensive line of advanced robotics solutions to customers.
Tetra Tech (TTEK) Wins $37M Single-Award Deal From USAID
by Zacks Equity Research
Tetra Tech's (TTEK) deal with USAID will require the company to support the socioeconomic empowerment of girls and women in Colombia.
Here's Why it is Worth Investing in Zebra (ZBRA) Stock Now
by Zacks Equity Research
Zebra (ZBRA) stands to benefit from strong demand environment for its products, acquired assets and solid cash flow.
Zacks.com featured highlights include: Titan Machinery, Sharps Compliance, MainStreet Bancshares, Fidelity National Financial and 1-800-FLOWERS.COM
by Zacks Equity Research
Zacks.com featured highlights include: Titan Machinery, Sharps Compliance, MainStreet Bancshares, Fidelity National Financial and 1-800-FLOWERS.COM
Sharps Compliance (SMED) Enters Oversold Territory
by Zacks Equity Research
Sharps Compliance (SMED) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
6 Top Ranked Stocks With Impressive Net Profit Margins
by Anirudha Bhagat
Let's take a look at these six top ranked stocks with solid net profit margins for a winning portfolio.
Envirotech Adoption Picks Up Pace: 5 Stock Choices
by Sreoshi Bera
Adoption of environmental technology to curb climate change puts Heritage-Crystal Clean (HCCI), Fuel Tech (FTEK), Sharps Compliance (SMED), Quest Resource (QRHC) and Clean Harbors (CLH) in spotlight
Sharps Compliance (SMED) Surges 5.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Sharps Compliance (SMED) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Down 23.1% in 4 Weeks, Here's Why Sharps Compliance (SMED) Looks Ripe for a Turnaround
by Zacks Equity Research
Sharps Compliance (SMED) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Donaldson (DCI) Beats Q3 Earnings Estimates, Raises FY21 View
by Zacks Equity Research
Donaldson's (DCI) Q3 earnings increase y/y on improvement in sales and margins. It raises expectations for fiscal 2021 on solid demand and backlog.
Sharps Compliance (SMED) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Sharps Compliance (SMED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Donaldson's (DCI) Board Okays 4.8% Hike in Dividend Rate
by Zacks Equity Research
Donaldson (DCI) hikes the quarterly dividend rate by 4.8% or 1 cent per share. The move is in sync with its shareholder-friendly policies.
Sharps Compliance (SMED) Is Up 1.05% in One Week: What You Should Know
by Zacks Equity Research
Does Sharps Compliance (SMED) have what it takes to be a top stock pick for momentum investors? Let's find out.